← Back to Clinical Trials
Recruiting NCT06949995

NCT06949995 Effects of Blood Flow Restriction on Post-Exercise Recovery in Amateur Runners

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06949995
Status Recruiting
Phase
Sponsor Paulista University
Condition Recovery Methods
Study Type INTERVENTIONAL
Enrollment 34 participants
Start Date 2025-10-27
Primary Completion 2026-08

Eligibility & Interventions

Sex Male only
Min Age 18 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Active Recovery with Blood Flow RestrictionActive Recovery

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 34 participants in total. It began in 2025-10-27 with a primary completion date of 2026-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Street running has become an increasingly popular sport. As a result, effective recovery strategies after exercise are essential. In this context, two techniques stand out: one already validated, active recovery (AR), and another with potential, blood flow restriction (BFR). This study aims to investigate whether using both techniques simultaneously can benefit practitioners and improve outcomes compared to complete rest.

Eligibility Criteria

Inclusion Criteria: * Individuals who present one or more of the following characteristics will not be included: * 1 presence of any health condition that contraindicates or prevents exercise; * 2 diabetes and diagnosed high blood pressure; * 3 inflammatory, psychiatric, cardiovascular and/or respiratory rheumatological disease; - -4 being dependent on alcohol, consuming drugs and/or being a smoker; * 5 history of knee surgery (e.g., meniscal repair and ligament reconstruction) or recent lower limb musculoskeletal injury that may impair performance during tests or interventions (e.g., muscle injury, tendinopathy, patellofemoral pain and/or back pain column in the last six months); * 6 use of ergogenic supplements to improve physical performance and/or muscle mass and/or vasoactive medications; * 7 having one or more risk factors predisposing to thromboembolism Exclusion Criteria: * Participants will be excluded from the study if they: * 1 have a health problem that does not allow them to continue; * 2 wish to leave the study; * 3 not sign the consent form

Contact & Investigator

Central Contact

Franciele Marques Vanderlei, PhD

✉ franmvanderlei@gmail.com

📞 +55 (18) 3229-5824

Frequently Asked Questions

Who can join the NCT06949995 clinical trial?

This trial is open to male participants only, aged 18 Years or older, up to 40 Years, studying Recovery Methods. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06949995 currently recruiting?

Yes, NCT06949995 is actively recruiting participants. Contact the research team at franmvanderlei@gmail.com for enrollment information.

Where is the NCT06949995 trial being conducted?

This trial is being conducted at Presidente Prudente, Brazil.

Who is sponsoring the NCT06949995 clinical trial?

NCT06949995 is sponsored by Paulista University. The trial plans to enroll 34 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology